New reporting items and recommendations for randomized trials impacted by COVID-19 and force majeure events: a targeted approach

por Leung, Tiffany H., Ho, James C., El Helali, Aya, Vokes, Everett E., Wang, Xiaofei, Pang, Herbert
Publicado 2023

Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer

por McGivern, Niamh, El-Helali, Aya, Mullan, Paul, McNeish, Iain A., Paul Harkin, D., Kennedy, Richard D., McCabe, Nuala
Publicado 2017

A meta-analysis with systematic review: Efficacy and safety of immune checkpoint inhibitors in patients with advanced gastric cancer

por El Helali, Aya, Tao, Jun, Wong, Charlene H. L., Chan, Wendy Wing-Lok, Mok, Ka-Chun, Wu, Wing Fong, Shitara, Kohei, Mohler, Markus, Boku, Narikazu, Pang, Herbert, Lam, Ka On
Publicado 2022

A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and oth...

por El Helali, Aya, Plummer, Ruth, Jayson, Gordon C., Coyle, Vicky M., Drew, Yvette, Mescallado, Nerissa, Harris, Noor, Clamp, Andrew R., McCann, Janine, Swaisland, Helen, Kennedy, Richard D., Cranston, Aaron N., Wilson, Richard H.
Publicado 2022

Perceptions about traditional Chinese medicine use among Chinese breast cancer survivors: A qualitative study

por Hung, Yik‐Laam, Leung, Siu‐Sing, Chiu, Siu‐Ting Pamela, Li, Pik‐Yi, Kan, Anson Chi‐On, Lo, Chi‐Chung, Wong, Sze‐Yuen Zeta, Luk, Sze‐Lam, Lai, Cheuk‐Lam Charlotte, El Helali, Aya, Chan, Wendy Wing‐Lok
Publicado 2022

The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours

por El Helali, Aya, Lam, Tai-Chung, Ko, Elaine Yee-Ling, Shih, David J.H., Chan, Chun Kau, Wong, Charlene H.L., Wong, Jason W.H., Cheung, Lydia W.T., Lau, Johnny K.S., Liu, Anthony P.Y., Chan, Ann S.Y., Loong, Herbert H., Lam, Stephen Tak Sum, Chan, Godfrey Chi-Fung, Lee, Victor H.F., Yuen, Kwok Keung, Ng, Wai-Tong, Lee, Anne W.M., Ma, Edmond S.K.
Publicado 2023

Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial

por Chiang, Chi Leung, Lam, Tai Chung, Li, James Chun Bong, Chan, Kenneth Sik Kwan, El Helali, Aya, Lee, Yolanda Yim Ping, Law, Laalaa Hiu Ting, Zheng, Danyang, Lo, Anthony Wing Ip, Kam, Ngar Woon, Li, Wing Sum, Cheung, Alice Ka Wai, Chow, James Chung Hang, Chan, Sunny Po Chung, Lai, Jessica Wing Yu, Lee, Sarah Wai Man, Kong, Feng-Ming (Spring), Ng, Wai Tong, Kwong, Dora Lai Wan, Lee, Anne Wing Mui
Publicado 2023

Consensus Statements on Precision Oncology in the China Greater Bay Area

por Lam, Tai-Chung, Cho, William Chi-Shing, Au, Joseph Siu-Kie, Ma, Edmond Shiu-Kwan, Lam, Stephen Tak-Sum, Loong, Herbert Ho-Fung, Wong, Jason Wing Hon, Wong, S.N. Michael, Lee, Victor Ho-Fun, Leung, Roland Ching-Yu, Lau, Johnny Kin-Sang, Kam, Michael Tsz-Yeung, Mok, Florence Siu-Ting, Lim, Fiona Mei-Ying, Nyaw, Jonathan Shi-Feng, Tin, Winnie Wing-Yan, Cheung, Ka-Man, Chan, Oscar Siu-Hong, Kwong, Philip Wai-Kay, Cheung, Foon-Yiu, Poon, Darren M.C., Chik, Jeannie Yin-Kwan, Lam, Martin Ho-Ching, Chan, Lawrence Wing-Chi, Wong, Sze-Chuen Cesar, Cao, Ya-Bing, Hui, Cheng-Vai, Chen, Jack Zhi-Jian, Chang, Jian-Hua, Kong, Spring Feng-Ming, El Helali, Aya
Publicado 2023